COMP <GO>
TECH vs KYMR // RSI-14 & 200D SMA MOMENTUM
Bio-Techne Corp (NASDAQ) VS. Kymera Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: TECH 7
— KYMR 5
▲ RSI-14 & 200D SMA MOMENTUM LEADER: KYMR
LAST: $72.67 (+0.01%) • MKT CAP: $11.39B
rsi-technicals
56.1
LAST: $127.51 (+0.70%) • MKT CAP: $10.81B
rsi-technicals
66.0
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECH VS. KYMR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TECH | KYMR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.80% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | -21.40% | +24.80 | TECH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 91.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.25% | -2.30% | +4.55 | TECH | /fcf-yield <GO> |
| Operating Margin | 8.40% | -60.00% | +68.40 | TECH | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 68.00% | -62.00 | KYMR | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | -16.70% | +21.90 | TECH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.44% | 0.00% | +0.44 | TECH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.12 | 26.00 | -18.88 | KYMR | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 4/9 | +4.00 | TECH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 56.1 | 66.0 | -9.90 | KYMR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.88 | 0.95 | -0.07 | KYMR | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 30.4x | +109.60 | KYMR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.39B | $10.81B | $583.8M | TECH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TECH REV | KYMR REV | TECH GROSS % | KYMR GROSS % | TECH FCF | KYMR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.22B | $39.2M | 64.8% | 0.0% | $256.6M | -$234.3M |
| FY 2024 | $1.16B | $47.1M | 66.4% | 0.0% | $236.1M | -$207.3M |
| FY 2023 | $1.14B | $78.6M | — | — | $203.2M | -$106.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECH // BETA 0.88
KYMR // BETA 0.95